Longeveron – This Biotech Company Is Using The Body's Own Cells To Fight Age-Related Diseases

Wa'el Hashad, CEO of Longeveron LGVN, was recently interviewed by Benzinga.

Longeveron is a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. Its lead investigational product, Lomecel-B, is derived from culture-expanded medicinal signaling cells (MSCs) that are sourced from bone marrow of young healthy adult donors. 

The company believes that by using the same cells that promote tissue repair, organ maintenance and immune system function, it can develop safe and effective therapies for some of the most difficult diseases and conditions associated with aging.

Watch the full interview here:

Featured photo by Louis Reed on Unsplash.

This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice.